Aloe Vera — Research Profile

Purified inner leaf gel juice (decolorized, aloin-free) is generally safe for daily use. Avoid whole-leaf products that contain aloe latex/aloin, which is a stimulant laxative that can cause dependence and electrolyte imbalances. Look for products certified by the International Aloe Science Council (IASC) and labeled "inner fillet" or "decolorized."

One well-designed RCT ^[1] showed aloe vera gel 100ml twice daily produced clinical remission in 30% of UC patients (vs 7% placebo). This is promising but needs replication in larger trials. Aloe vera should be used as complementary therapy alongside conventional UC treatment, not as a replacement.

The inner leaf (gel/fillet) is the clear, mucilaginous part with anti-inflammatory polysaccharides — this is the beneficial component. The outer leaf contains latex with anthraquinones like aloin, which are harsh stimulant laxatives. Whole-leaf products contain both and may cause diarrhea, cramping, and long-term safety concerns. Always choose inner leaf/decolorized products.

For oral digestive use, decolorized inner-leaf gel or juice is the form studied in the positive trials for ulcerative colitis and GERD and is the safer choice. Aloe latex, the yellow sap just under the rind, acts as a stimulant laxative and is not appropriate for routine or long-term intake. Non-decolorized whole-leaf extract should be avoided because of its anthraquinone content and IARC carcinogenicity classification.

The best oral evidence is for gut and metabolic outcomes. A randomized trial of aloe gel 100 mL twice daily produced clinical remission in 30% of mild-to-moderate ulcerative colitis patients versus 7% on placebo, a GERD trial cut reflux symptom frequency over 4 weeks, and a meta-analysis found oral aloe lowered fasting glucose by 46.6 mg/dL and HbA1c by 1.05% in prediabetic and diabetic adults. These are mostly small trials, so the findings are promising rather than definitive.

No standardized dose is established, and amounts varied widely by preparation and goal in the trials. Ulcerative colitis was studied at 100 mL of aloe gel twice daily, whereas the GERD study used just 10 mL/day of a syrup standardized to 5.0 mg polysaccharide per mL. Because concentration differs enormously between products, follow the specific product's label rather than assuming these study volumes are interchangeable.

Optimal time of day has not been directly compared in trials. The ulcerative colitis study simply used a twice-daily schedule and the GERD study a once-daily dose, without testing timing against meals or bedtime. For reflux, taking it around meals is a reasonable practical choice, but no head-to-head data establish a best time.

With purified inner-leaf gel, trials reported only minor adverse events similar to placebo. The bigger concerns come from aloe latex, which causes abdominal pain, cramps, and diarrhea, and from leaf extracts, which have been associated with cases of acute hepatitis. Oral aloe may be unsafe in pregnancy and breastfeeding.

Yes. Because oral aloe can lower fasting glucose by roughly 46.6 mg/dL and HbA1c by about 1.05%, it may add to the effect of insulin or oral diabetes drugs and increase hypoglycemia risk. NCCIH also warns that overuse of aloe latex can raise the risk of adverse effects from cardiac glycosides such as digoxin, likely through laxative-driven potassium loss. Anyone on prescription medication should clear oral aloe with their prescriber first.

Adults with mild-to-moderate ulcerative colitis, reflux symptoms, or elevated blood sugar are the groups with the most supportive oral trial data, though the evidence is preliminary. It is not appropriate during pregnancy or breastfeeding, where NCCIH considers oral aloe possibly unsafe, and people on diabetes or cardiac-glycoside medications should use it only under medical supervision. Latex-containing whole-leaf products are best avoided by everyone.

Onset depends on the use. In a controlled GERD trial, 10 mL/day of aloe vera syrup reduced heartburn and regurgitation over 4 weeks, with symptom scores assessed at weeks 2 and 4. A ulcerative colitis trial gave oral aloe gel for 4 weeks before measuring remission, and glycemic trials pooled by meta-analysis typically ran several weeks. Expect a trial of at least 2 to 4 weeks rather than an immediate effect.

Long-term safety is not established. NCCIH notes that research supports short-term use of oral aloe gel for up to 42 days, but oral aloe leaf extracts have been linked to cases of acute hepatitis with use ranging from as little as 3 weeks to as long as 5 years. Chronic use of aloe latex (the laxative fraction) is discouraged because of cramping, diarrhea, and potential electrolyte loss.

Yes. There is no established tolerable upper intake level, and the toxicity depends on the preparation. Oral aloe latex can cause abdominal pain, cramps, and diarrhea, and the International Agency for Research on Cancer classifies non-decolorized whole-leaf aloe extract (not carbon-treated to remove anthraquinones) as a possible human carcinogen. Purified inner-leaf gel or juice carries far less of this risk, but leaf-extract products have still been implicated in acute hepatitis.

The main caution is with anything else that lowers blood sugar. A meta-analysis found oral aloe vera reduced fasting blood glucose by 46.6 mg/dL and HbA1c by 1.05%, so stacking it with berberine, cinnamon, or other glucose-lowering supplements could push blood sugar too low. Aloe latex products also have a laxative effect that can compound with other stimulant-laxative or potassium-depleting supplements.

Choose a decolorized inner-leaf gel or juice, which has been carbon-filtered to remove aloin and other anthraquinones; avoid non-decolorized whole-leaf extract, which IARC classifies as a possible carcinogen. Products standardized to their active fraction are preferable, for example the GERD-trial syrup was standardized to 5.0 mg polysaccharide per mL. Check that the label specifies inner-leaf (fillet) rather than whole-leaf or latex.